Scarica l'app Stockscreener
1.48
4.96%
0.07
Dopo l'orario di chiusura:
1.48
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CAMP Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$1.41
Aprire:
$1.44
Volume 24 ore:
28,994
Relative Volume:
0.28
Capitalizzazione di mercato:
$29.84M
Reddito:
$264.74M
Utile/perdita netta:
$-49.71M
Rapporto P/E:
-0.3613
EPS:
-4.0959
Flusso di cassa netto:
$-43.55M
1 W Prestazione:
+0.00%
1M Prestazione:
-9.76%
6M Prestazione:
-67.04%
1 anno Prestazione:
+270.00%
Intervallo 1D:
$1.44
$1.54
Intervallo di 1 settimana:
$1.41
$1.64
Portata 52W:
$1.305
$12.30
Camp 4 Therapeutics Corp Stock (CAMP) Company Profile
Nome
Camp 4 Therapeutics Corp
Settore
Industria
Telefono
617-651-8867
Indirizzo
ONE KENDALL SQUARE, CAMBRIDGE, CA
Confronta CAMP con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CAMP
Camp 4 Therapeutics Corp
|
1.48 | 31.45M | 264.74M | -49.71M | -43.55M | -4.0959 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Camp 4 Therapeutics Corp Stock (CAMP) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-27 | Iniziato | Wedbush | Outperform |
| 2024-11-05 | Iniziato | JP Morgan | Overweight |
| 2024-11-05 | Iniziato | Piper Sandler | Overweight |
| 2024-11-05 | Iniziato | William Blair | Outperform |
| 2022-08-16 | Aggiornamento | Craig Hallum | Hold → Buy |
| 2021-12-22 | Downgrade | Craig Hallum | Buy → Hold |
| 2021-09-24 | Reiterato | Craig Hallum | Buy |
| 2021-06-25 | Reiterato | Craig Hallum | Buy |
| 2020-12-18 | Downgrade | JP Morgan | Neutral → Underweight |
| 2020-04-17 | Aggiornamento | Jefferies | Hold → Buy |
| 2020-03-05 | Reiterato | Craig Hallum | Buy |
| 2019-12-20 | Reiterato | Craig Hallum | Buy |
| 2019-12-20 | Downgrade | First Analysis Sec | Outperform → Neutral |
| 2019-06-28 | Aggiornamento | Northland Capital | Market Perform → Outperform |
| 2019-05-29 | Downgrade | Goldman | Neutral → Sell |
| 2019-05-01 | Reiterato | Craig Hallum | Buy |
| 2019-03-25 | Downgrade | JP Morgan | Overweight → Neutral |
| 2019-01-25 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2018-12-21 | Aggiornamento | Craig Hallum | Hold → Buy |
| 2018-12-14 | Reiterato | B. Riley FBR | Buy |
| 2018-12-11 | Downgrade | First Analysis Sec | Strong Buy → Outperform |
| 2018-12-11 | Downgrade | Northland Capital | Outperform → Market Perform |
| 2018-11-27 | Iniziato | Goldman | Neutral |
| 2018-10-15 | Iniziato | Jefferies | Hold |
| 2018-09-28 | Reiterato | Craig Hallum | Hold |
| 2018-04-27 | Reiterato | Craig Hallum | Hold |
| 2018-03-08 | Downgrade | Craig Hallum | Buy → Hold |
| 2018-02-16 | Aggiornamento | First Analysis Sec | Equal-Weight → Overweight |
Mostra tutto
Camp 4 Therapeutics Corp Borsa (CAMP) Ultime notizie
Does Camp4 Therapeutics Corporation meet Warren Buffett’s criteriaMarket Movement Recap & Weekly High Return Stock Forecasts - khodrobank.com
Is Camp4 Therapeutics Corporation showing signs of accumulationJuly 2025 Breakouts & Free Verified High Yield Trade Plans - Newser
Real time social sentiment graph for Camp4 Therapeutics CorporationJuly 2025 Summary & Comprehensive Market Scan Reports - Newser
Market reaction to Camp4 Therapeutics Corporation’s recent newsTrade Risk Assessment & Verified Swing Trading Watchlists - Newser
Will Camp4 Therapeutics Corporation rebound enough to break even2025 Trade Ideas & Weekly Top Performers Watchlists - Newser
Using Python tools to backtest Camp4 Therapeutics Corporation strategies2025 Historical Comparison & Stepwise Swing Trade Plans - Newser
Tick level data insight on Camp4 Therapeutics Corporation volatilityMarket Performance Summary & Precise Swing Trade Alerts - Newser
Analyzing drawdowns of Camp4 Therapeutics Corporation with statistical toolsJuly 2025 Selloffs & AI Driven Price Predictions - Newser
What to expect from Camp4 Therapeutics Corporation in the next 30 daysLong Setup & Fast Entry and Exit Trade Plans - Newser
Is Camp4 Therapeutics Corporation a speculative investmentJuly 2025 Rallies & Entry Point Strategy Guides - khodrobank.com
Can trapped investors hope for a rebound in Camp4 Therapeutics CorporationWeekly Trend Recap & Technical Pattern Based Signals - Newser
How sentiment analysis helps forecast Camp4 Therapeutics Corporation2025 Geopolitical Influence & Safe Investment Capital Preservation Plans - Newser
Is Camp4 Therapeutics Corporation stock suitable for long term investing2025 Stock Rankings & Proven Capital Preservation Methods - khodrobank.com
Published on: 2025-09-02 23:28:06 - Newser
Can Camp4 Therapeutics Corporation deliver alpha2025 Key Highlights & Verified Short-Term Trading Plans - khodrobank.com
Does Camp4 Therapeutics Corporation show high probability of reboundJuly 2025 Macro Moves & Weekly Consistent Profit Watchlists - Newser
Combining machine learning predictions for Camp4 Therapeutics CorporationEarnings Beat & Expert Curated Trade Setups - Newser
Real time scanner hits for Camp4 Therapeutics Corporation explainedVolume Spike & Weekly Watchlist for Hot Stocks - Newser
Will a bounce in Camp4 Therapeutics Corporation offer an exitQuarterly Profit Report & Risk Managed Investment Strategies - Newser
Published on: 2025-09-02 04:40:20 - Newser
Can Camp4 Therapeutics Corporation rally from current levelsTrade Exit Summary & Verified Entry Point Signals - Newser
Published on: 2025-09-01 20:25:26 - Newser
Recap Report: Is Camp4 Therapeutics Corporation a defensive stockTrade Entry Summary & Risk Controlled Daily Plans - خودرو بانک
Is Camp4 Therapeutics Corporation’s ROE strong enoughMarket Volume Report & Daily Risk Controlled Trade Plans - khodrobank.com
Is Camp4 Therapeutics Corporation stock bottoming outMarket Volume Summary & Long Hold Capital Preservation Tips - Newser
Using portfolio simulators with Camp4 Therapeutics Corporation includedWeekly Earnings Recap & AI Powered Buy/Sell Recommendations - Newser
What machine learning models say about Camp4 Therapeutics CorporationMarket Activity Recap & Daily Stock Trend Watchlist - Newser
Using data filters to optimize entry into Camp4 Therapeutics CorporationTrade Exit Report & Low Drawdown Trading Strategies - Newser
Sector ETF performance correlation with Camp4 Therapeutics CorporationJuly 2025 Trends & Safe Capital Growth Tips - Newser
Advanced analytics toolkit walkthrough for Camp4 Therapeutics Corporation2025 Trade Ideas & Fast Entry Momentum Trade Alerts - Newser
Applying Elliott Wave Theory to Camp4 Therapeutics Corporation2025 Pullback Review & Weekly Market Pulse Alerts - Newser
What recovery options are there for Camp4 Therapeutics CorporationEarnings Growth Report & Expert Verified Movement Alerts - Newser
Will breakout in Camp4 Therapeutics Corporation lead to full recoveryShare Buyback & Free Verified High Yield Trade Plans - Newser
Camp 4 Therapeutics Corp Azioni (CAMP) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Camp 4 Therapeutics Corp Azioni (CAMP) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| AH Equity Partners Bio I, L.L. | 10% Owner |
Oct 15 '24 |
Buy |
11.00 |
727,272 |
7,999,992 |
1,579,885 |
| Enavate Sciences GP, LLC | 10% Owner |
Oct 15 '24 |
Buy |
11.00 |
1,363,636 |
14,999,996 |
3,785,802 |
| Polaris Management Co. VII, L. | 10% Owner |
Oct 15 '24 |
Buy |
11.00 |
909,090 |
9,999,990 |
909,090 |
| 5AM Partners VI, LLC | 10% Owner |
Oct 15 '24 |
Buy |
11.00 |
909,090 |
9,999,990 |
2,625,145 |
| Nashat Amir | Director |
Oct 15 '24 |
Buy |
11.00 |
909,090 |
9,999,990 |
909,090 |
| Schwab Andrew J. | Director |
Oct 15 '24 |
Buy |
11.00 |
909,090 |
9,999,990 |
2,625,145 |
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):